Laser photocoagulation
Laser photocoagulation is a medical procedure with 22 clinical trials. Currently 1 active trials ongoing. Historical success rate of 88.9%.
Success Metrics
Based on 16 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
6
Mid Stage
10
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
88.9%
16 of 18 finished
11.1%
2 ended early
1
trials recruiting
22
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Extension Study to Evaluate the Long-term Outcomes of Subjects in Study 20090
Combination of Ranibizumab and Targeted Laser Photocoagulation
Panretinal Photocoagulation for Proliferative Diabetic Retinopathy in a Single Session Using Low Fluence Parameters
Study to Assess the Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Compared to Laser Photocoagulation in Patients With Retinopathy of Prematurity
The Analysis of Association of Retinopathy of Prematurity, Gut Microbiome Profile, and Systemic Inflammation
Clinical Trials (22)
Extension Study to Evaluate the Long-term Outcomes of Subjects in Study 20090
Combination of Ranibizumab and Targeted Laser Photocoagulation
Panretinal Photocoagulation for Proliferative Diabetic Retinopathy in a Single Session Using Low Fluence Parameters
Study to Assess the Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Compared to Laser Photocoagulation in Patients With Retinopathy of Prematurity
The Analysis of Association of Retinopathy of Prematurity, Gut Microbiome Profile, and Systemic Inflammation
Ranibizumab for Treatment of Persistent Diabetic Neovascularization Assessed by Wide-Field Imaging
Comparison of Treatments in Diabetic Macular Edema
Aflibercept for Retinopathy of Prematurity - Intravitreal Injection Versus Laser Therapy
A Safety and Efficacy Study of Dexamethasone Versus Laser Photocoagulation in Participants With Diabetic Macular Edema
Ranibizumab Treatment for Macular Edema Secondary to Retinal Vein Occlusion
Safety and Efficacy of a New Treatment in Combination With Laser for Diabetic Macular Edema
Clinical Efficacy of Bevacizumab Combined With Navigated Laser in Patients With Clinically Significant Macula Edema
The Ranibizumab for Edema of the mAcula in Diabetes-2 (READ-2) Study
Efficacy and Safety of Ranibizumab (Intravitreal Injections) Versus Laser Treatment in Patients With Visual Impairment Due to Diabetic Macular Edema
The Course of Response to Focal Photocoagulation for DME
A Phase 2 Evaluation of Anti-VEGF Therapy for Diabetic Macular Edema: Bevacizumab (Avastin)
Laser Versus Vitrectomy Versus Intravitreal Triamcinolone Injection for Diabetic Macular Edema
DME And VEGF Trap-Eye [Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321)] INvestigation of Clinical Impact
Intravitreal Bevacizumab and Triamcinolone Associated to Laser Photocoagulation for Diabetic Macular Edema(IBeTA)
Efficacy and Safety of Ranibizumab (Intravitreal Injections) in Patients With Visual Impairment Due to Diabetic Macular Edema
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 22